Feb 10, 2012 08:05AM Insmed (INSM) Commences ARIKACE Phase 2 in NTM Lung Disease Patients, Phase 3 in CF Patients w/ Pa
Feb 9, 2012 05:47PM NeurogesX (NGSX) Confirms FDA Panel Did Not Recommend Approval of Qutenza

1 news item has been posted to this category today.
Sign-up to StreetInsider.com Premium to see all today's market moving FDA reports.